Hands pouring hot water over chamomile flowers in teapot
on August 15, 2026

Apigenin for Sleep: What the Evidence Actually Shows

Apigenin, a plant flavonoid found most abundantly in chamomile, does show plausible sleep-supporting and calming effects — but the honest answer is that the human evidence is still limited, and the popular 50 mg isolated supplement has never been tested in a randomized clinical trial. Chamomile extract (the form actually studied in people) shows modest, directionally positive signals for anxiety and sleep, while isolated apigenin’s benefits in humans remain largely inferred from animal research. That gap matters, and you deserve to know it upfront.

Quick safety callout: Apigenin and chamomile extract are generally well-tolerated at typical doses, but they are not appropriate for everyone. Avoid them during pregnancy, if you take anticoagulants like warfarin, or if you use prescription sedatives or benzodiazepines. Always check with a healthcare professional before starting any new supplement.

Here’s what this guide covers:

  • Mechanism: Apigenin appears to act as a partial agonist at GABA-A benzodiazepine receptor sites, which could explain mild calming and sedative effects.
  • Human evidence: Chamomile extract trials show mixed but directionally favorable results for sleep and stronger signals for anxiety reduction; no RCT has tested isolated 50 mg apigenin for sleep.
  • Practical use: Chamomile tea is the lowest-risk starting point; standardized chamomile extract is closest to what trials used; isolated apigenin supplements are the most experimental option.

Key Takeaways

Chamomile extract has the strongest human evidence for sleep and anxiety support, while isolated 50 mg apigenin supplements remain experimental with no published RCT evidence at that dose.

Point Details
Human evidence is limited The Zick 2011 pilot (34 adults, 540 mg/day, 28 days) found directionally favorable but not statistically significant sleep improvements.
Anxiety pathway may matter most Chamomile extract showed significant anxiety reduction in a randomized trial, suggesting sleep benefits may come via reduced pre-sleep anxiety.
Dose gap is significant Chamomile extract trials delivered roughly 3–18 mg of apigenin; popular isolated supplements deliver 50 mg with no RCT backing at that dose.
Safety caveats are real Avoid apigenin and chamomile extract during pregnancy, with anticoagulants, or alongside prescription sedatives without medical guidance.
Fromwithin’s approach Fromwithin’s non-melatonin sleep aid offers ingredient transparency and evidence-grounded formulation for adults who want natural sleep support.

Table of Contents

What apigenin is and where it comes from

Apigenin (4’,5,7-trihydroxyflavone) is a naturally occurring flavone, a subclass of plant flavonoids, found in a wide range of fruits, vegetables, and herbs. It is not a hormone, not a sedative drug, and not melatonin. Think of it as a plant compound that interacts gently with certain receptors in your nervous system — more on that in the next section.

The richest dietary sources include:

  • Chamomile (Matricaria chamomilla): By far the most concentrated source, and the one used in virtually all human trials. Dried chamomile flowers contain apigenin at levels that make it the go-to herbal form.
  • Parsley: One of the highest food sources by weight, though most people eat it in small garnish amounts.
  • Celery: A moderate source, contributing to daily flavonoid intake in people who eat it regularly.
  • Other herbs and vegetables: Thyme, oregano, and certain leafy greens contain smaller amounts.

When it comes to supplements, you’ll encounter three main formats, and they are not interchangeable:

Format Typical apigenin content Practicality
Chamomile tea (dried flowers, brewed) Low and variable; depends on steep time and flower quality Easy, low-cost, lowest risk
Standardized chamomile extract (capsule/tablet) Labeled as “X% apigenin” — e.g., 1.2% of 540 mg = ~6.5 mg apigenin Moderate; closest to what human trials used
Isolated apigenin supplement (capsule) Typically 50 mg per capsule — far higher than extract trials delivered Convenient but most experimental; no RCT at this dose

Supplement labels can be confusing. A product simply labeled “50 mg apigenin” is a very different thing — it’s a concentrated, isolated form at a dose that no published human trial has specifically evaluated for sleep.

How apigenin might support sleep and calm your nervous system

The most studied mechanism is apigenin’s interaction with GABA-A receptors, specifically at the benzodiazepine binding site. GABA (gamma-aminobutyric acid) is your brain’s primary inhibitory neurotransmitter — it slows neural activity and promotes calm. Benzodiazepine drugs like diazepam work by binding to a specific site on GABA-A receptors and amplifying GABA’s effect. Apigenin appears to act as a partial agonist at this same site, meaning it nudges the receptor in a similar direction but with much less intensity. That’s why it’s described as calming rather than sedating at typical doses, and why it doesn’t carry the same dependence risk as prescription benzodiazepines. Early pharmacology work identifying apigenin as a GABA-A benzodiazepine-site ligand laid the foundation for this understanding.

Beyond GABA-A, a few other pathways are worth knowing about:

  • Anti-inflammatory and antioxidant effects: Apigenin modulates certain cytokine pathways and reduces oxidative stress in cell and animal studies. Chronic low-grade inflammation is increasingly linked to poor sleep quality, so this pathway could contribute indirectly.
  • NAD+/CD38 pathway: Some researchers have noted that apigenin inhibits CD38, an enzyme that degrades NAD+ (a molecule central to cellular energy and aging). This has generated interest in longevity circles, but it is firmly preclinical and speculative at this stage.
  • Anxiolytic effects: Separate from direct sedation, apigenin’s calming action on the nervous system may reduce pre-sleep anxiety, which is one of the most common barriers to falling asleep. This anxiolytic pathway may actually be the most clinically relevant mechanism for sleep.

Key mechanistic insight: Apigenin’s GABA-A partial agonism is the most pharmacologically plausible explanation for its calming effects. The anti-inflammatory and NAD+ pathways are interesting but remain unconfirmed in human pharmacokinetic studies. Most of what we know about these mechanisms comes from cell cultures and rodent models, not from measuring apigenin’s effects in the human brain.

A detailed narrative review covering apigenin’s GABA-A activity, animal sleep effects, and the NAD+ aging connection provides the most thorough current summary of these mechanisms and is candid about where the human evidence falls short.

What animal studies tell us (and what they can’t)

Rodent studies have been the primary testing ground for apigenin’s sleep and anxiety effects, and the results are generally encouraging — with important caveats about translating them to people.

Species Dose / Route Main outcome Key limitation
Mice Moderate oral dose Reduced anxiety-like behavior in open-field and elevated plus-maze tests Rodent anxiety models don’t map cleanly to human anxiety disorders
Mice Higher intraperitoneal injection Increased sleep duration and reduced sleep latency Injected doses bypass first-pass metabolism; oral bioavailability is much lower
Rats Oral apigenin Mild sedative effects at higher doses; anxiolytic at lower doses Dose scaling from rodent to human body weight is not straightforward
Mice (magnesium + apigenin combination) Combined oral dosing Increased sleep duration versus either compound alone Combination effects complicate isolating apigenin’s contribution

A few consistent patterns emerge from this body of work. Anxiolytic effects (reduced anxiety-like behavior) appear at lower doses, while sedative effects (actual sleep promotion) tend to require higher doses. One preclinical study found that combining apigenin with magnesium produced greater sleep duration than either alone, which is why you’ll often see these two ingredients paired in sleep supplement stacks. That said, the combination finding makes it harder to attribute the effect to apigenin specifically.

The most important limitation is bioavailability and route of administration. Many rodent studies used intraperitoneal injection, which delivers apigenin directly into circulation and bypasses the gut entirely. When you swallow an apigenin capsule, absorption is considerably lower and more variable. The brain concentrations achieved in injected rodent studies may simply not be reachable through oral supplementation in humans at typical doses.

Human clinical evidence: what trials have actually tested

This is where the picture gets more nuanced, and where the honest answer matters most.

Chamomile extract trials

The most-cited human sleep trial is the Zick et al. 2011 pilot study: 34 adults with primary insomnia received 540 mg of standardized chamomile extract daily for 28 days. The results? Directionally favorable on some outcomes, but no statistically significant improvement on the primary sleep diary measures. It’s a small pilot, not a definitive trial, and it was never designed to be one.

The Amsterdam 2009 chamomile anxiety trial is actually the stronger of the two human findings. It showed a meaningful reduction in anxiety scores versus placebo, which is relevant to sleep because pre-sleep anxiety is one of the most common reasons people can’t fall asleep. If chamomile extract helps quiet an anxious mind before bed, that’s a plausible indirect route to better sleep quality.

The isolated apigenin gap

Here’s something worth stating plainly: no published randomized controlled trial has tested isolated 50 mg apigenin for sleep in humans. The popular 50 mg dose traces to podcast recommendations rather than clinical trial data, and the chamomile extract trials that do exist delivered far less apigenin than that (more on the math in the next section). As Home Wellness Science summarizes, the evidence gap between chamomile extract trials and isolated apigenin supplements is real and significant.

Evidence strength summary:

  • Well-supported: Chamomile extract has shown some signs of anxiolytic effects in humans in limited clinical studies.
  • Suggestive but inconclusive: Chamomile extract may have some positive effects on sleep quality, though evidence is limited and not definitive.
  • Mechanistically plausible but untested in humans: Isolated 50 mg apigenin for sleep — no RCT evidence at this dose.
  • Preclinical only: NAD+/CD38 pathway, combination synergy with magnesium.

Bioavailability: why the form you take really matters

Apigenin’s oral bioavailability is a genuine challenge. When you swallow an isolated apigenin capsule, it faces first-pass metabolism in the gut and liver before reaching systemic circulation. The result is that a meaningful portion of the dose may be broken down before it can act. Examine flags low oral bioavailability as a key concern for isolated apigenin and notes that most positive human findings come from chamomile extract studies, not isolated supplements.

Glass jars with botanical extracts and capsules on table

Why might chamomile extract behave differently? The extract contains a full matrix of plant compounds — flavonoids, terpenoids, and other phytochemicals — that may influence how apigenin is absorbed and metabolized. Drinking chamomile tea or taking a standardized extract gives you lower apigenin but a broader botanical context. An isolated supplement gives you more apigenin on paper, but absorption efficiency and the absence of co-occurring compounds may change the actual effect.

The dose math is striking. Chamomile extract trials typically used extracts standardized to approximately 1.2% apigenin, meaning a 540 mg extract delivers roughly 6.5 mg of apigenin. Trials across the range of 220–1,500 mg extract correspond to approximately 3–18 mg of apigenin. The popular 50 mg isolated supplement delivers substantially more apigenin than chamomile extract trials, but this higher dose has not been tested clinically.

Practical comparison:

  • Chamomile tea: Lowest apigenin content, most variable, but also the lowest risk and the most accessible starting point.
  • Standardized chamomile extract: Closest to what human trials used; look for “standardized to X% apigenin” on the label.
  • Isolated apigenin (50 mg): Highest apigenin per serving; lowest bioavailability certainty; no direct RCT evidence at this dose.
  • Dietary sources (parsley, celery): Contribute to daily flavonoid intake but at amounts too low to expect a meaningful acute sleep effect.

Pro Tip: When reading a chamomile extract label, multiply the total extract milligrams by the stated apigenin percentage (as a decimal) to estimate actual apigenin content. That context helps you compare products and understand what the trials actually tested.

For a broader look at how bioavailability affects supplement efficacy, clinically tested beauty supplements face the same absorption challenges, and the same label-reading principles apply.

Reported doses, timing, and how long to give it a fair trial

What doses appear in the evidence

  • Chamomile extract (human trials): 220–1,500 mg of standardized extract per day, corresponding to roughly 3–18 mg of apigenin. The Zick 2011 insomnia pilot used 540 mg/day.
  • Isolated apigenin (popular supplement protocol): 50 mg per capsule, typically taken once before bed. This dose is not derived from clinical trial data — it became popular through podcast recommendations.
  • Chamomile tea: No standardized dose; one to two cups brewed from dried flowers is the common practice, delivering a few milligrams of apigenin at most.

Timing guidance

Take apigenin-containing products 30–60 minutes before your intended bedtime. This window allows time for absorption and aligns with when you’d want any calming effect to begin. Avoid daytime dosing if you’re sensitive to sedative effects — even mild drowsiness can affect alertness, which matters if you’re working or driving. For practical guidance on building a consistent bedtime supplement routine, bedtime supplement best practices walks through timing and stacking considerations.

Running a fair trial

  1. Choose one form — don’t switch between chamomile tea, extract, and isolated apigenin during the trial. Single-variable testing is the only way to know what’s working.
  2. Commit to 2–4 weeks — sleep changes are gradual, and a few nights of data tells you very little.
  3. Track specific outcomes — note sleep latency (how long it takes to fall asleep), number of nighttime awakenings, and how you feel in the morning. A simple sleep diary or app works well.
  4. Keep other variables stable — don’t start a new exercise program, change your caffeine intake, or adjust other supplements at the same time.

Population modifiers: Older adults may experience stronger sedative effects at the same dose due to changes in liver metabolism and receptor sensitivity. Anyone with liver impairment should use caution with any concentrated botanical extract and consult a clinician before starting.

Safety, side effects, and drug interactions you should know about

Apigenin and chamomile extract are generally well-tolerated, but “natural” does not mean risk-free. Here’s what the evidence and clinical caution suggest.

Common mild side effects

  • Mild gastrointestinal upset (nausea, stomach discomfort) — more common with higher doses or on an empty stomach.
  • Headache, reported occasionally in chamomile extract trials.
  • Rare paradoxical effects: some people report feeling more alert rather than calmer, particularly at lower doses.

Serious interactions and contraindications

Warning: Do not use apigenin or chamomile extract if you are pregnant or breastfeeding, taking anticoagulant medications (especially warfarin), or currently using prescription sedatives or benzodiazepines. These are not minor cautions — they represent real risks of harm. If any of these apply to you, speak with your doctor before considering any chamomile-based supplement.

Here’s why each of these matters:

  • Anticoagulants (warfarin and similar drugs): Chamomile contains coumarin compounds that may potentiate anticoagulant effects, increasing bleeding risk. This interaction is well-documented enough to warrant a hard stop.
  • Benzodiazepines and prescription sedatives: Combining apigenin’s GABA-A activity with prescription sedatives could amplify sedation unpredictably. This is not a theoretical concern — it’s a pharmacological overlap that warrants medical supervision.
  • CYP450 interactions: Apigenin may inhibit certain cytochrome P450 enzymes involved in drug metabolism, potentially affecting the blood levels of other medications you take. If you’re on any regular prescription medication, check for interactions with a pharmacist or clinician.
  • Pregnancy and breastfeeding: Chamomile has a long history of use, but concentrated extracts and isolated apigenin have not been tested for safety in pregnancy. The precautionary recommendation is to avoid them entirely.
  • Estrogen-sensitive conditions: Apigenin has mild phytoestrogenic activity in some cell studies. The clinical significance in humans is unclear, but people with hormone-sensitive conditions (certain breast cancers, endometriosis) should discuss this with their oncologist or specialist before use.

When to stop and seek advice: If you experience unusual bruising, significant drowsiness that affects daily function, allergic reactions (especially if you have ragweed or daisy-family allergies, as chamomile is in the same botanical family), or any unexpected symptom, stop the supplement and consult a clinician.

How to source apigenin-containing products safely in Singapore

Singapore’s Health Sciences Authority (HSA) oversees health supplements under the Health Products Act, but supplements are not individually approved the way prescription medicines are. That means the responsibility for choosing a quality product falls largely on you as the consumer.

Here’s a practical checklist for Singapore shoppers:

  • Ingredient transparency: The label should clearly list the extract form (e.g., “Matricaria chamomilla flower extract”), the standardization percentage (e.g., “standardized to 1.2% apigenin”), and the total extract amount per serving.
  • Third-party testing: Look for products that have been tested by an independent laboratory for purity, potency, and absence of contaminants. Certifications from NSF International, USP, or similar bodies are a good signal.
  • GMP manufacturing: Products manufactured under Good Manufacturing Practice (GMP) conditions have more consistent quality control. This is often stated on the label or the brand’s website.
  • Compliant labeling: Products sold in Singapore should comply with HSA labeling requirements. Avoid products making therapeutic claims (e.g., “treats insomnia”) on the label, as these cross into regulated medicine territory.
  • Declare supplement use to your healthcare provider: This is especially important if you take any prescription medications or have a chronic health condition.

Where to buy: Local pharmacies (Guardian, Watsons, Unity) carry chamomile-based products and some standardized extracts. Reputable direct-to-consumer wellness brands with transparent ingredient sourcing are another option. For isolated apigenin supplements, online purchasing is common, but apply the same quality checklist above — and be more cautious, given the lack of RCT evidence at that dose.

Pro Tip: When comparing products online, search the brand name alongside “certificate of analysis” (COA). A legitimate supplement brand will provide third-party lab results confirming that what’s on the label is actually in the capsule. If a brand doesn’t publish or share COAs on request, that’s a meaningful red flag.

For broader guidance on what to look for in a sleep supplement, finding the right sleep supplement covers the key evaluation criteria in plain language.

The practical verdict: where to start and who should think twice

If you’re considering apigenin for sleep, here’s a prioritized, evidence-aware approach:

  1. Start with chamomile tea. It’s the lowest-risk, most accessible option. Brew one to two cups from dried chamomile flowers 30–60 minutes before bed. The apigenin content is low and variable, but the ritual itself supports good sleep hygiene, and the risk profile is minimal for most healthy adults.

  2. Step up to standardized chamomile extract if tea doesn’t seem to help after two to four weeks. This is the form closest to what human trials used. Look for a product standardized to a stated apigenin percentage, and use the label math (extract mg × apigenin %) to understand what you’re actually getting. The Zick 2011 pilot used 540 mg/day — a reasonable reference point.

  3. Consider isolated apigenin (50 mg) as an experimental option only after you’ve tried the above and want to explore further. Go in with clear expectations: this dose has not been tested in a human RCT for sleep, and the bioavailability of isolated apigenin is uncertain. Treat it as a personal experiment, track your outcomes carefully, and don’t combine it with other sedatives.

Who should avoid or seek clinician input first:

  • Anyone who is pregnant or breastfeeding.
  • Anyone taking warfarin or other anticoagulants.
  • Anyone using prescription sedatives, benzodiazepines, or other CNS-active medications.
  • Anyone with a hormone-sensitive condition.
  • Older adults or those with liver impairment, who may need dose adjustments.

One final thought: if you’re dealing with chronic insomnia, no supplement — apigenin included — replaces Cognitive Behavioral Therapy for Insomnia (CBT-I), which has the strongest evidence base of any intervention for long-term sleep improvement. Chamomile or apigenin may be a helpful complement to good sleep habits, but they work best alongside them, not instead of them. And better sleep has real downstream benefits, including for your skin — the connection between sleep and skin appearance is well-documented and worth understanding.

What we think about apigenin at Fromwithin

At Fromwithin, we take an evidence-first approach to everything we recommend. Apigenin is genuinely interesting — the GABA-A mechanism is pharmacologically plausible, the chamomile extract trials show real (if modest) signals, and the safety profile for most healthy adults is reasonable. What we won’t do is overstate the evidence. The popular 50 mg isolated supplement is ahead of the clinical data, and we think you deserve to know that before spending money on it.

What this means practically: chamomile extract is the most defensible starting point if you want to try apigenin for sleep support. Isolated supplements are worth exploring only once you’ve tried the evidence-adjacent options and understand the uncertainty involved. And if you’re on any medication, the conversation with your doctor comes first, always.

Fromwithin’s non-melatonin sleep support

If you’re looking for a sleep aid that’s transparent about its ingredients and doesn’t rely on melatonin or hormones, Fromwithin’s sleep aid was built with exactly that in mind. It’s designed for busy adults who want to wind down naturally without worrying about next-morning grogginess or long-term dependence.

Fromwithin

Every ingredient is clearly listed, and the formulation is grounded in the same evidence-first thinking that runs through everything Fromwithin makes. If you’re currently on any medications or are pregnant or breastfeeding, please check with your healthcare provider before adding any supplement to your routine. When you’re ready to explore, the full supplement range is a good place to start.

Sources

The following sources were used to support the claims in this article. Each is linked directly so you can verify the evidence yourself.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.